| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.49T | 1.37T | 1.41T | 1.28T | 1.02T |
| Gross Profit | 442.59B | 428.64B | 435.17B | 377.95B | 279.99B |
| EBITDA | 223.52B | 238.01B | 237.03B | 200.28B | 159.44B |
| Net Income | 77.61B | 81.43B | 93.29B | 70.17B | 75.83B |
Balance Sheet | |||||
| Total Assets | 1.87T | 1.79T | 1.84T | 1.66T | 1.44T |
| Cash, Cash Equivalents and Short-Term Investments | 142.07B | 178.46B | 177.07B | 141.85B | 119.52B |
| Total Debt | 571.00B | 610.42B | 649.82B | 579.26B | 414.54B |
| Total Liabilities | 905.56B | 933.05B | 1.02T | 958.20B | 769.48B |
| Stockholders Equity | 904.07B | 809.34B | 763.38B | 659.99B | 611.61B |
Cash Flow | |||||
| Free Cash Flow | 130.69B | 98.86B | 17.43B | -85.28B | 4.78B |
| Operating Cash Flow | 174.13B | 143.93B | 73.03B | -26.14B | 39.32B |
| Investing Cash Flow | -49.55B | -52.83B | -39.03B | -61.67B | -6.85B |
| Financing Cash Flow | -144.54B | -85.37B | -8.92B | 106.11B | -25.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $414.16B | 30.12 | 45.10% | 0.98% | 4.29% | -14.76% | |
73 Outperform | $159.33B | 54.83 | 18.93% | 1.34% | -2.66% | -21.47% | |
67 Neutral | $7.07B | 15.89 | 11.16% | 1.24% | 5.73% | -32.67% | |
66 Neutral | $7.40B | 14.10 | 9.16% | 3.70% | 3.40% | -8.70% | |
66 Neutral | $9.79B | 12.46 | 14.57% | 1.56% | -3.10% | -3.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | $13.29B | 22.56 | 6.58% | 2.67% | -8.81% | -60.95% |